Patent / Trademark Law
Patent / Trademark Law Newswire (Page 4)

Patent / Trademark Law Newswire (Page 4)

Comprehensive Real-Time News Feed for Patent / Trademark Law. (Page 4)

Results 61 - 80 of 17,193 in Patent / Trademark Law

  1. Story from NorthCountryNow.comRead the original story

    Wednesday Aug 26 | North Country Now

    A SUNY Canton instructional support associate has invented a new and more reliable way to oil the bar and chain on commercial chainsaws. Neil A. Haney of Chase Mills came up with an idea for improvements while building a homebuilt firewood-processing machine.

    Comment?

  2. Fresenius Medical Care North America Receives Safety In Excellence Award From CNA For 16th YearRead the original story w/Photo

    Wednesday Aug 26 | Sys-Con Media

    KGaA, the recipient of the national CNA Safety in Excellence Award. This award recognizes a company's national leadership and dedicated commitment to employee health, safety, loss prevention and risk control.

    Comment?

  3. Barracuda Coming Back As A Dodge?Read the original story w/Photo

    Wednesday Aug 26 | MotorAuthority

    Fiat Chrysler Automobiles [NYSE:FCAU] is currently holding its dealer group meeting in Las Vegas, during which it's showing the people who sell its vehicles the future of the company. Late last night our sources informed us that a new Barracuda is not only coming, but that it was shown in convertible form.

    Comment?

  4. Post-Grant Proceedings: The Top Seven Things You Should Know About the Proposed Rule ChangesRead the original story w/Photo

    Wednesday Aug 26 | JD Supra

    On August 20th, the U.S. Patent and Trademark Office published proposed rules that would amend the consolidated set of rules currently governing Inter Partes Reviews, Post-Grant Reviews, Covered Business Method Reviews, and Derivation proceedings before the Office. Here are the top seven things patent practitioners and their clients should know about the proposed rules.

    Comment?

  5. Why musicians look to Congress for change - PTO floats new change...Read the original story

    Wednesday Aug 26 | Politico

    The music industry has been pressing Congress for more than a year now to overhaul the way musicians and other artists are compensated for their work. Neil Portnow, president of The Recording Academy, has been helping lead the charge to change music licensing practices both through legislation and through agreements overseen by the Justice Department.

    Comment?

  6. Cass Awarded U.S. Patent for Its TEM Mobile AppRead the original story

    Wednesday Aug 26 | Freshnews

    The United States Patent and Trademark Office has awarded Cass Information Systems, Inc. , a leading provider of telecom expense management , managed mobility services and Bring Your Own Device solutions , with U.S. Patent No. 9,105,056, which is directed to a mobile app that enables access to telecom expense data from smartphones and other wireless devices.

    Comment?

  7. The PTAB's Proposed Rule ChangesRead the original story w/Photo

    Wednesday Aug 26 | jdsupra.com

    The Patent Office conducted a nationwide listening tour in April and May of 2014 to gauge the effectiveness of the rules governing post-grant proceedings , post-grant reviews and covered business method patent reviews ) at the Patent Trial and Appeal Board . In June 2014, the Office published a Federal Register Notice asking for public feedback regarding the post-grant proceedings.

    Comment?

  8. Mylan Confirms The Review Proceedings Against Two Copaxone 40 Mg/Ml Dosing PatentsRead the original story

    Tuesday Aug 25 | BioSpace

    Mylan Confirms The U.S. Patent And Trademark Office Institutes Inter Partes Review Proceedings Against Two Copaxone 40 Mg/Ml Dosing Patents /PRNewswire/ -- Mylan N.V. today announced that the U.S. Patent and Trademark Office has instituted inter partes review proceedings against two CopaxoneA 40 mg/mL patents, U.S. Patent Nos. 8,232,250 and 8,399,413, owned by Yeda Research & Development Co., Ltd. and licensed to Teva Pharmaceuticals Industries Ltd. The patents relate to methods for the treatment of multiple sclerosis through the administration of at least three 40 mg subcutaneous injections of glatiramer acetate over a period of seven days with at least one day between each injection.

    Comment?

  9. MTF Receives Favorable Ruling From The Patent Trial And Appeal...Read the original story

    Tuesday Aug 25 | BioSpace

    8,372,437 and 8,323,701 . On the PTAB ruled in favor of MTF by granting an IPR proceeding for the '437 patent, stating that there is "a reasonable likelihood that [MTF] would prevail in showing claims 1 and 2 of the '437 patent are unpatentable" .

    Comment?

  10. Corium International, Inc. Announces Issuance Of U.S. Patent For...Read the original story

    Tuesday Aug 25 | BioSpace

    Corium International, Inc. , a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that the United States Patent and Trademark Office issued U.S. Patent No. 9,114,238 on August 25, 2015, related to Corium's innovative MicroCor A transdermal system.

    Comment?

  11. BIO Statement On IPR DecisionsRead the original story

    Tuesday Aug 25 | BioSpace

    The Biotechnology Industry Organization (BIO) today released the following statement on the decision by the U.S. Patent and Trademark Office rejecting challenges to two patents held by Acorda Therapeutics. Help employers find you! Check out all the jobs and post your resume .

    Comment?

  12. No Winners in Appeal Over 'Testmasters' MarkRead the original story w/Photo

    Tuesday Aug 25 | Courthouse News Service

    Two competing providers of test-preparation courses do not deserve nationwide trademark registration, and one is in contempt for harassing the other, the Fifth Circuit ruled. Founded in 1991, Test Masters Educational Services Inc. dba Testmasters started offering test-preparation courses in 1992, mostly in Houston, but has since expanded out of state.

    Comment?

  13. Marvell Technology Group (MRVL) - Research Analysts' Weekly Ratings ChangesRead the original story w/Photo

    Wednesday Aug 26 | AmericanBankingNews.com

    A number of firms have modified their ratings and price targets on shares of Marvell Technology Group recently: 8/23/2015 - Marvell Technology Group had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $17.00 price target on the stock.

    Comment?

  14. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Tuesday Aug 25 | Business Wire

    16, in Chica... )--Citrix Systems, Inc. today announced that David Henshall, chief operations officer and chief financial officer, will present at the Citibank 2015... )--U.S. Property/casualty insurers' operating performance remained essentially unchanged in the first half of 2015, with $25.5 billion in aggregate operating earnings reporte... )--Fitch Ratings has assigned a 'BBB+' rating on the following revenue bonds issued by the Wisconsin Health and Educational Facilities Authority on behalf of Saint John's Com... )--Fitch Ratings has completed a portfolio review covering 12 Latin American insurance groups focused exclusively on application of Fitch's recently updated notching criteria... )--MusclePharm Corporation , a scientifically driven, performance-lifestyle sports nutrition company, today announced plans to better focus and align the company'... )--Fitch Ratings has upgraded to ... (more)

    Comment?

  15. PTO Proposed Pilot Program on IPR InitiationRead the original story

    Tuesday Aug 25 | Patently Obvious

    Inter Partes Review Trials have become an effective tool for cancelling invalid patent claims that lack novelty or fail the nonobviousness test. The IPR process has two main stages: Institution and Trial .

    Comment?

  16. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs...Read the original story

    Tuesday Aug 25 | Benzinga

    Mylan N.V. today announced that the U.S. Patent and Trademark Office has instituted inter partes review proceedings against two CopaxoneA 40 mg/mL patents, U.S. Patent Nos. 8,232,250 and 8,399,413, owned by Yeda Research & Development Co., Ltd. and licensed to Teva Pharmaceuticals Industries Ltd. The patents relate to methods for the treatment of multiple sclerosis through the administration of at least three 40 mg subcutaneous injections of glatiramer acetate over a period of seven days with at least one day between each injection.

    Comment?

  17. 'Sheer ridiculousness' or fair play? USPTO turns down patent challengeRead the original story w/Photo

    Tuesday Aug 25 | In-PharmaTechnologist.com

    The US Patent and Trademark Office has refused to review a challenge to Acorda Therapeutics' patents from a group trying to block " abusive " IP claims. Hedge fund manager Kyle Bass, who also runs the Coalition for Affordable Drugs, filed a review for two patents on Acorda's 10mg Ampyra extended release tablets for multiple sclerosis.

    Comment?

  18. Bio Statement on Uspto Ipr DecisionsRead the original story

    Tuesday Aug 25 | Freshnews

    The Biotechnology Industry Organization today released the following statement on the decision by the U.S. Patent and Trademark Office rejecting challenges to two patents held by Acorda Therapeutics. "We applaud the decision by the U.S. Patent and Trademark Office to reject hedge fund manager Kyle Bass' challenge of two of Acorda's patents.

    Comment?

  19. Acorda Therapeutics Inc (ACOR)'s Shares Jump After Dismissal Of...Read the original story w/Photo

    Tuesday Aug 25 | Insider Monkey

    The shares of Acorda Therapeutics Inc are trading 13.16% higher today after the dismissal of a patent challenge against the company. Kyle Bass of Hayman Advisors was leading the group challenging two patents held by the pharmaceutical firm for its Multiple Sclerosis drug, Ampyra.

    Comment?

  20. Legal teams keep bending old laws to fit cybercrimesRead the original story w/Photo

    Tuesday Aug 25 | ITworld

    Since cybercrime laws lag behind technology, lawyers are constantly seeking creative ways to stretch old laws to fit new crimes, such as the latest - comparing the movie-sharing app Popcorn Time to a burglar's tool in order to press criminal charges. Lawyers for an Adam Sandler movie are arguing that Popcorn Time performs the same function as burglars' tools in order "to commit or facilitate a a theft by physical taking," language used in an old Oregon law about traditional burglary.

    Comment?